(2) CJC-1295 CJC-1295 is a synthetic peptide designed to stimulate the release of growth hormone (GH) to help improve muscle development, metabolize fat, improve ones energy levels, and recover quicker after intensive workouts or injuries
70 HP 130 AOD-9604 HGH Fragment 176-191 Lipolytic ALIASES AOD-9604, AOD9604, hGH(176-191), Tyr-hGH(177-191) CLASS Synthetic growth-hormone C-terminal fragment lipolytic candidate FORMULA CHNOS SEQUENCE 16-residue fragment corresponding to hGH(177-191) with N-terminal Tyrosine addition HALF-LIFE Short (minutes) plasma ROUTES Subcutaneous (Phase 2 obesity) Oral (food-supplement contexts in some jurisdictions) MECHANISM OF ACTION Synthetic 15-amino-acid fragment of human growth hormone (residues 176-191)
More recent evidence indicates that sustained GIP receptor agonism in the presence of GLP-1 activation enhances insulin sensitivity and may preferentially reduce visceral adipose tissue
Combined in one oral formulation, these compounds offer a versatile platform for examining cellular recovery, metabolic support, and structural integrity in various systems
Some semaglutide formulations also have both B6 and B12 to help relieve side effects, such as nausea, or prevent lethargy and fatigue in patients taking GLP-1 drugs for weight loss or type 2 diabetes
It has been clarified in the Glucocorticoids Washout Table that use of sustained-release formulations may result in detectable glucocorticoid levels past the washout period due to prolonged systemic absorption